id,collection,Authors,Date,Language,MeSH Headings,MeSH qualifiers,Publisher,Subject or keywords,Title,Type,dc.date.accessioned,dc.date.available,dc.identifier.govdoc,dc.identifier.uri
"187643","10665/87475","Assemblée mondiale de la Santé, 18","1965","fr","Pharmaceutical Preparations::Pharmaceutical Preparations::600||Quality Control::Quality Control::600||Drug Industry::Drug Industry::600||Organizational Case Studies::Organizational Case Studies::600||Health Promotion::Health Promotion::600||Efficiency, Organizational::Efficiency, Organizational::600||Program Development::Program Development::600||Smallpox::Smallpox::600||Smallpox Vaccine::Smallpox Vaccine::600||National Health Programs::National Health Programs::600||Financial Support::Financial Support::600||International Cooperation::International Cooperation::600","standards||prevention and control||supply and distribution","Organisation mondiale de la Santé","Pharmaceutical products||Smallpox","Cinquième rapport de la Commission du Programme et du Budget","Governing body documents","2015-09-21T08:27:23Z","2015-09-21T08:27:23Z","A18/16","https://iris.who.int/handle/10665/184884"
